1. Home
  2. SEPN vs SMC Comparison

SEPN vs SMC Comparison

Compare SEPN & SMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SEPN
  • SMC
  • Stock Information
  • Founded
  • SEPN 2022
  • SMC 2009
  • Country
  • SEPN United States
  • SMC United States
  • Employees
  • SEPN N/A
  • SMC N/A
  • Industry
  • SEPN
  • SMC
  • Sector
  • SEPN
  • SMC
  • Exchange
  • SEPN NYSE
  • SMC NYSE
  • Market Cap
  • SEPN 311.6M
  • SMC 363.3M
  • IPO Year
  • SEPN 2024
  • SMC 2012
  • Fundamental
  • Price
  • SEPN $6.69
  • SMC $28.43
  • Analyst Decision
  • SEPN Buy
  • SMC
  • Analyst Count
  • SEPN 4
  • SMC 0
  • Target Price
  • SEPN $33.00
  • SMC N/A
  • AVG Volume (30 Days)
  • SEPN 181.2K
  • SMC 69.1K
  • Earning Date
  • SEPN 05-19-2025
  • SMC 05-07-2025
  • Dividend Yield
  • SEPN N/A
  • SMC N/A
  • EPS Growth
  • SEPN N/A
  • SMC N/A
  • EPS
  • SEPN N/A
  • SMC N/A
  • Revenue
  • SEPN $1,075,000.00
  • SMC $444,383,000.00
  • Revenue This Year
  • SEPN N/A
  • SMC N/A
  • Revenue Next Year
  • SEPN N/A
  • SMC N/A
  • P/E Ratio
  • SEPN N/A
  • SMC N/A
  • Revenue Growth
  • SEPN 611.92
  • SMC N/A
  • 52 Week Low
  • SEPN $4.17
  • SMC $25.00
  • 52 Week High
  • SEPN $28.99
  • SMC $45.89
  • Technical
  • Relative Strength Index (RSI)
  • SEPN N/A
  • SMC 44.95
  • Support Level
  • SEPN N/A
  • SMC $25.00
  • Resistance Level
  • SEPN N/A
  • SMC $29.38
  • Average True Range (ATR)
  • SEPN 0.00
  • SMC 1.61
  • MACD
  • SEPN 0.00
  • SMC 0.32
  • Stochastic Oscillator
  • SEPN 0.00
  • SMC 66.99

About SEPN SEPTERNA INC

Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform. Its industrial-scale platform aims to unlock the full potential of GPCR therapies. The group discovery and development of a pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic disease. Its pipeline includes SEP-786 (PTH1R), SEP-631 (MRGPRX2), TSHR, GLP-1R, GIPR, and GCGR.

About SMC SUMMIT MIDSTREAM CORPORATION

Summit Midstream Corp is a value-driven corporation focused on developing, owning and operating midstream energy infrastructure assets strategically located in unconventional resource basins, shale formations, in the continental U.S. It currently operates natural gas, crude oil and produced water gathering systems in four unconventional resource basins: the Williston Basin in North Dakota, which includes the Bakken and Three Forks shale formations; the Denver-Julesburg Basin, which includes the Niobrara and Codell shale formations in Colorado and Wyoming; the Fort Worth Basin in Texas, which includes the Barnett Shale formation; and the Piceance Basin in Colorado, which includes the liquids-rich Mesaverde formation as well as the emerging Mancos and Niobrara Shale formations.

Share on Social Networks: